Biovica International AB TEMP Class B's next confirmed earnings release is scheduled for December 17, 2026.
| Earnings Date | 12/17/2026 |
As of July 31, 2026, Biovica International AB TEMP Class B has 291.91M shares outstanding.
| Shares Outstanding | 291.91M |
As of July 31, 2026, Biovica International AB TEMP Class B maintains a current ratio of 3.06, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 9.05, indicating elevated leverage, while an interest coverage ratio of -219.02 demonstrates limited ability to service its debt obligations.
| Current Ratio | 3.06 |
| Quick Ratio | 2.63 |
| Debt / Equity | 9.05 |
| Debt / EBITDA | -0.10 |
| Interest Coverage | -219.02 |
Over the twelve months ended July 31, 2026, Biovica International AB TEMP Class B posted a negative return on equity (ROE) of -156.59, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -98.35, reflecting losses generated across the asset base. The company generates approximately 593,080.00 in revenue per employee across its workforce of 25.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.26 indicates how many times Biovica International AB TEMP Class B sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -156.59 |
| Return on Assets (ROA) | -98.35 |
| Revenue Per Employee | 593,080.00 |
| Employee Count | 25.00 |
| Inventory Turnover | 0.26 |
Over the twelve months ended July 31, 2026, Biovica International AB TEMP Class B recorded 1.57M in income tax expense. The company reported a pretax loss of -70.66M and -72.23M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 1.57M |
As of the close on October 28, 2026, Biovica International AB TEMP Class B's stock has declined approximately 48.39% over the past 52 weeks.
| 52-Week Price Change | -48.39% |
Over the twelve months ended July 31, 2026, Biovica International AB TEMP Class B generated 14.83M in revenue and converted that into -72.23M in net income, yielding earnings per share of -0.25. EBITDA reached -63.30M, while operating income came in at -71.65M.
| Revenue | 14.83M |
| Gross Profit | 14.36M |
| Operating Income | -71.65M |
| Pretax Income | -70.66M |
| Net Income | -72.23M |
| EBITDA | -63.30M |
| EBIT | -71.12M |
| Earnings Per Share (EPS) | -0.25 |
As of July 31, 2026, Biovica International AB TEMP Class B holds 51.59M in cash and equivalents against 6.02M in total debt, resulting in a net debt position of -51.59M. Total book value stands at 66.57M, with working capital of 40.43M providing operational flexibility.
| Cash & Cash Equivalents | 51.59M |
| Total Debt | 6.02M |
| Net Debt | -51.59M |
| Equity (Book Value) | 66.57M |
| Book Value Per Share | 0.23 |
| Working Capital | 40.43M |
Biovica International AB TEMP Class B produced -61.71M in operating cash flow over the twelve months ended July 31, 2026. After subtracting -2.32M in capital expenditures, free cash flow totaled -64.04M - equivalent to -0.23 per share.
| Operating Cash Flow | -61.71M |
| Capital Expenditures | -2.32M |
| Free Cash Flow | -64.04M |
| FCF Per Share | -0.23 |
Over the twelve months ended July 31, 2026, Biovica International AB TEMP Class B posted a gross margin of 96.85, reflecting its pricing power and cost economics. The operating margin of -483.21 and net profit margin of -487.17 provide insight into operational efficiency.
| Gross Margin | 96.85 |
| Operating Margin | -483.21 |
| Pretax Margin | -476.56 |
| Profit Margin | -487.17 |
| EBITDA Margin | -426.90 |
Already premium?